Global Healthcare CMO Market to Reach US$246.5 bn by 2019, Asia Pacific to Report Highest Growth


Posted July 1, 2016 by MarketTrends

The market for contract manufacturing shows tremendous potential due to growth in the medical device industry, growing regulatory concerns and increasing demand from emerging countries.

 
Contract manufacturing outsourcing (CMO) involves outsourcing of certain manufacturing activities that were previously performed by the producer to a third-party. It is an emerging trend in the global healthcare industry. Nowadays, most of the medical and pharmaceutical devices manufacturers are outsourcing production activities to contract manufacturers in order to reduce production cost without compromising on the product quality or to achieve expertise in a specific business segment, which is not available in-house.

According to the report, the presence of a skilled workforce at a low price in emerging economies has encouraged companies involved in the production of medical and pharmaceutical devices to outsource certain manufacturing activities, propelling the global healthcare CMO market significantly. The restructuring of manufacturing procedures and other activities involved in the production of medical and pharmaceutical devices has also strengthened the contract manufacturing outsourcing trend in the global healthcare industry.

Avail a Free Sample Report: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2452

The report analyzes the global healthcare CMO market on the basis of the type of service and the regional spread of this market. Based on the service type, the market has been broadly classified into pharmaceutical CMO services and medical device CMO services. The pharmaceutical CMO services segment dominated the global market with a share of 55.4% in 2012.

Based on its regional spread, the research report has segmented the global healthcare CMO market into North America, Asia Pacific, Europe, and the Rest of the World. North America occupied the leading position in the overall market in 2012. However, Asia Pacific is likely to register expansion at the fastest CAGR of 17.80% over the forecast period.

The implementation of favorable regulations and policies by various governments across the world, amendments in intellectual property protection rights, and the augmented uptake of novel technologies are the key factors driving the growth of the Asia Pacific healthcare CMO market.

Additionally, the low labor cost and several tax benefits are also projected to fuel the healthcare CMO market in Asia Pacific, states the research study.

Symmetry Medical Inc., Piramal Healthcare, Patheon Inc., Lonza Group, Greatbatch Inc., Fareva, DSM, Catalent Pharma Solutions Inc., Boehringer Ingelheim GmbH, and Accellent Inc. are some of the major companies functional in the global healthcare CMO market, mentioned in this research report.

Browse Full Research Report: http://www.transparencymarketresearch.com/healthcare-cmo-market.html

About Us
Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By MarketTrends
Website Transparency Market Research
Phone +1-518-618-1030
Business Address State Tower, 90 State Street, Suite 700
Albany, NY 12207 United States
Country United States
Categories Health
Tags global healthcare cmo market , healthcare cmo market
Last Updated July 1, 2016